Should I Get a Flu Shotprint friendly version
Making an Informed Decision
Like many of you, I have pondered whether or not getting the flu shot for me and my family is wise. There seem to be many conflicting reports out there, concerning what this shot truly contains. Recently, a friend of mine brought home 2 listings of the ingredients contained in the flu shot vaccination. She picked each one up from a different health-related organization. What was surprising, is that the ingredient listings were very different, although they were describing the same vaccine. So, how can we make an informed decision when we don't know the truth?
I recently received a very informative article written by Dr. John F. Coombs of Fallbrook, Ontario, Canada on the H1N1 Swine Flu Pandemic. He does not tell you whether or not you should get the H1N1 vaccine, but he does tell you what the risks of getting it and not getting it are so you are able to make an informed decision. Below I have included some of his key points, but I encourage you to read the entire .pdf article that follows this information.
Who Should Have the H1N1 Vaccine?
Dr. Coombs says:
I would be more inclined to administer H1N1 immunization to those who have serious medical conditions that would make them more vulnerable to H1N1 flu, and to those who are extremely frightened by the H1N1 flu epidemic. On the other hand, for those who are already in a state of neural activation (like autistic children) we need to seriously consider possible adverse consequences of the shot. The H1N1 vaccine, especially with its squalene and thimerosal, is likely to increase neural activation, according to Dr. Russell Blaylock, a neurosurgeon who is alerting the public on this issue. For these children, I would be inclined to avoid the H1N1 shot, and rely upon the preventive measures outlined in this article. Those who understand and follow sound health principles are also likely to do better in the long run relying on the preventive measures outlined here, rather than the vaccine...
There is Widespread Hesitancy About the H1N1 Flu Vaccine - And There are Reasons For This
Dr. Coombs goes on to say:
- The vaccines that have been tested are not the same vaccines you & your children will be given
The Canadian vaccine is being produced in Ste-Foy, Quebec, by GlaxoSmithKline under the trade name Arepanrix. Approval of the Canadian H1N1 vaccine was done on the basis of studies done in Belgium by GlaxoSmithKline in 130 people, using a mock vaccine with a different virus than that used in the present vaccine. Health Canada reviewed the manufacturing process, but not the actual vaccine that is now being produced. [This is the same scenario that happened in the 1976 swine flu vaccine disaster. They tested one vaccine and gave a different one during the mass vaccinations. The CDC had advance warning about concerns about neurological complications of the vaccine, but the warnings went unheeded. More people than were affected by the vaccine than by swine flu itself: over 500 people were paralyzed with Guillain Barre disorder, and over 300 people died before the vaccine was pulled off the market. ]
- There are concerns about adverse effects of the squalene adjuvant used in the vaccine.
Adjuvants are immune system stimulators that increase the immune response to a vaccine. The H1N1 vaccine contains an oil-based adjuvant primarily composed of squalene. This is the first time that a squalene adjuvant has been used in Canada. It has been evaluated by Health Canada during its review of the vaccine production process used by GSK in Europe, and is said by them to have no significant safety concerns in its use in approximately 45,000 people. However, more than two dozen peer-reviewed scientific papers from ten different laboratories throughout the U.S., Europe, Asia, and Australia have been published documenting the development of autoimmune disease in animals subjected to squalene-based adjuvants. According to Anthony Fauci, director of the National Institutes of Allergy and Infectious Diseases, testing in the United States in both children and adults has been without this adjuvant and he admits that we have no data on the safety of the adjuvant in children. (See Nature Vol 460/30 July 2009, p 562 for the interview.) [An adjuvant-free version of the vaccine will be available in Ontario for use in pregnant women and children between 6 months and 3 years of age.]
- The vaccine contains thimerosal
The vaccine will have thimerosal (an ethylmercury salt) added to the vaccine as a preservative. The amount of thimerosal in each dose of vaccine is said by public health authorities to be safe, but their definition of safety is based on the principle of averages, and does not define risk for those who are particularly sensitive to mercury. Most physicians providing biomedical treatment for autism have definite concerns about the toxicity of ethyl mercury, especially in pregnant women and infants.
- The H1N1 Vaccine has been fast-tracked
According to a number of studies, vaccine contamination is widespread, with vaccines containing pestivirus, mycoplasma, viral fragments, DNA fragments and bacterial components, all of which can produce chronic systemic disorders, cancer, and neurological diseases. This vaccine has been fast-tracked, meaning that many of the usual safety precautions used to prevent contamination of the vaccines will be overlooked by the regulatory agencies.
- Some Previous Studies Suggest That Influenza Vaccine Is No Sure Fire Prevention
The vaccine is being promoted as though it were a clearly effective prevention for H1N1 influenza. Previous studies have shed doubt on the overall effectiveness of influenza vaccines in general [see article below for full details]
- There is Increasing Documentation for Hazards to Over-Immunization
There is evidence accumulating that our ‘one-size-fits-all’ mass immunization programs are causing damage to a much larger proportion of the population than we previously have realized. This is a concern that deals with the immunization program as a whole more than the question of a single H1N1 influenza shot, but the issue of over-immunization has to be kept in mind. The hazards of over-immunization are being recognized by veterinarians in cats, dogs, and horses, but are publically acknowledged by only a few physicians. Here are two who do raise the issue:
Dr. Russell Blaylock is a neurosurgeon who has written extensively on over-immunization and immune activation, and their association with autoimmune diseases, autism, and dementia. His website presents his concerns: http://www.russellblaylockmd.com/ .
Dr. Andrew Moulden, a Canadian M.D. with extensive training in neuroscience, presents compelling evidence regarding a link between immunization, hyper-coagulability, and micro-vascular neurological damage (mini-strokes), and their association with neuro-developmental disorders in children (including autism, ADD, and learning disorders). Visit his web site, www.BrainGuardMD.com , for more information, including the DVD set called ‘Tolerance Lost’
Read The Full Article
Dr. John Coombs on H1N1 (.pdf)
Please leave your comments. I'd love your feedback on this article.